Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Discover
Back to filter
Show all topics (10)
Related topics
WEBINAR: Recent Advancements In Neurodegenerative Biomarkers
Sep 6, 2021
Recent Advancements in Neurodegenerative Biomarkers: Progress Towards a Diagnostic Blood Test for Alzheimer’s Disease
How to Improve Your Viral Nucleic Acid Extraction Processes
Sep 6, 2021
High-Throughput Extraction with CyBio FeliX
Introducing New Aura 4.0 software
Aug 31, 2021
With new features for both acquisition & analysis Aura Software enables you to capture and analyze your data quickly,...
Comparison of gamma and x-ray irradiation results
Aug 12, 2021
Biological effects of Cs-137 and X-ray irradiators are comparable with regards to...
Hypoxia further exacerbates myopathy in broilers via alteration of satellite cell fate
Aug 2, 2021
Woody breast (WB) condition has created a variety of challenges for the global poultry...
High quality Bioluminescence and X-Ray analysis in lung squamous cell carcinoma
Jul 21, 2021
Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence,...
Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility
Jul 15, 2021
6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full...
ACCELA webinar recording : IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jul 15, 2021
Intravital microscopy can visualize...
Webinar recording: Autofluorescence management - the power of Spectral Flow Cytometry
Jul 15, 2021
One of the key advantages of spectral flow cytometry is its ability to extract sample...
Webinar recording: Super-Resolution imaging of Chromatin organization in health and disease
Jul 9, 2021
Understanding how cells organize the array of components within their membranous confines can not only provide insight...
Differentation displacement in acute myeloid leukemia through enhancer activation
Aug 7, 2018
LSD1 is a flavin adenine dinucleotide (FAD)-dependent homolog of the amine oxidase family and there was recently brought attention to it as a potential therapeutic target. The interest came from an observation of unusually high expression of LSD1 in certain types of poor-prognosis cancers. It was previously thought that LSD1 removes monomethyl and dymethyl histone marks. However, recently it was showed that it interacts with multiple transcripton factor. This raised a possibility of other drugs being used.
New inhibitor ORY-1001 was succesfully tested on LSD1 and blast cell differentioation was observed. The flow cytometric testing on this experiment was done with Novocyte. ORY-1001 disrupts the protein interaction between LSD1 and GFI1.
Related technologies: Conventional flow cytometry
Brand profile
